Correlation Between Neurocrine Biosciences and Haleon Plc
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Haleon Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Haleon Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Haleon plc, you can compare the effects of market volatilities on Neurocrine Biosciences and Haleon Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Haleon Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Haleon Plc.
Diversification Opportunities for Neurocrine Biosciences and Haleon Plc
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Neurocrine and Haleon is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Haleon plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Haleon plc and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Haleon Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Haleon plc has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Haleon Plc go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Haleon Plc
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 1.26 times more return on investment than Haleon Plc. However, Neurocrine Biosciences is 1.26 times more volatile than Haleon plc. It trades about 0.09 of its potential returns per unit of risk. Haleon plc is currently generating about 0.03 per unit of risk. If you would invest 13,130 in Neurocrine Biosciences on January 31, 2024 and sell it today you would earn a total of 759.00 from holding Neurocrine Biosciences or generate 5.78% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Neurocrine Biosciences vs. Haleon plc
Performance |
Timeline |
Neurocrine Biosciences |
Haleon plc |
Neurocrine Biosciences and Haleon Plc Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neurocrine Biosciences and Haleon Plc
The main advantage of trading using opposite Neurocrine Biosciences and Haleon Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Haleon Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Haleon Plc will offset losses from the drop in Haleon Plc's long position.Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Haleon Plc vs. Teva Pharma Industries | Haleon Plc vs. Bausch Health Companies | Haleon Plc vs. Zoetis Inc | Haleon Plc vs. Takeda Pharmaceutical Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |